EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

News in Gastric Cancer

News from around the world, curated by the Gastric Cancer Foundation.

Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients

A prospective study in Gut Journal quantifies the cancer risk associated with each gastritis stage.

Share Post:

Prognostic significance of the preoperative ratio of C-reactive protein to albumin and neutrophil–lymphocyte ratio in gastric cancer patients

FDA approves new treatment for certain digestive tract cancers

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 6279
Albany, CA 94706

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

2 days ago

Final results from a phase 3 trial of chemotherapy combined with the immunotherapy drug Imfinzi (durvalumab), given before and after surgery in gastric cancer patients, produced an overall survival rate of 69% at 36 months, vs. 62% for placebo. One author suggested the regimen could be a new standard of care for patients eligible for surgery. Via @CancerNetwrk ... See MoreSee Less

Perioperative Durvalumab Combo Boosts Survival in Resectable Gastric Cancer | CancerNetwork

www.cancernetwork.com

Final phase 3 MATTERHORN data position perioperative durvalumab plus FLOT as a new standard in resectable gastric or gastroesophageal junction adenocarcinoma.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

4 days ago

A team of European researchers scoured data from more than 450,000 people involved in a long-term study and found that high levels of processed meat consumption were associated with increased gastric cancer risk. Although the study was not designed to uncover the causes behind this association, the authors suggested that chemicals used to prepare the meats, byproducts of protein digestion and high salt content could be contributing factors. Via International Journal of Cancer ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Gastric cancer patients receiving chemotherapy experience high levels of nausea, pain and fatigue that should be addressed with personalized symptom-management regimens, argue the authors of a new study. This should improve supporting proper nutrition and quality of life, they said. Gastric Cancer Foundation offers several resources to support patients in this journey, including our Gesundheit Kitchen video series and online support network Smart Patients. ... See MoreSee Less

Nausea, Pain, and Fatigue Emerge as Core Gastric Cancer Symptoms - Oncology Nurse Advisor

www.oncologynurseadvisor.com

Researchers evaluated nutrition impact symptoms in patients with gastric cancer receiving chemotherapy to identify distinct symptom burden profiles.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 weeks ago

A recent study found that the risk of gastric cancer is higher for people who drink one sugar-sweetened beverage per day than it is for those who have never consumed sugary drinks. The authors found no association between artificially sweetened drinks and gastric cancer, however. Check out this summary of the findings in Oncology Nurse Advisor ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 weeks ago

Authors of an analysis comparing studies of five drug regimens that include Vyloy (zolbetuximab) in gastric cancer concluded that biomarker testing is essential to selecting the most appropriate treatment for individual patients. In some patients with HER2-negative, CLDN 18.2-positive disease, Vyloy combined with chemotherapy may be comparable to immunotherapy-driven regimens, they found. Gastric Cancer Foundation was a founding partner of the national Test Your Biomarkers campaign and we continue to emphasize the importance of biomarker testing in gastric cancer. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X